GI Innovation, Inc. (KOSDAQ:358570)
15,200
+90 (0.60%)
At close: Mar 6, 2026
GI Innovation Revenue
GI Innovation had revenue of 338.09M KRW in the twelve months ending September 30, 2025, down -92.89% year-over-year. In the year 2024, GI Innovation had annual revenue of 24.28M, down -99.54%.
Revenue (ttm)
338.09M
Revenue Growth
-92.89%
P/S Ratio
2,881.37
Revenue / Employee
n/a
Employees
n/a
Market Cap
974.15B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medy-Tox | 241.80B |
| Onconic Therapeutics | 46.65B |
| Pharmicell | 23.94B |
| MEDIPOST | 73.59B |
| Green Cross Holdings | 2,397.09B |
| Chabiotech | 1,197.69B |
| Orum Therapeutics | 25.48M |
| SillaJen | 7.84B |